Kyle Bauser Analyst Performance

Kyle Bauser is a stock analyst at Roth Capital focused in the medical sector, covering 20 publicly traded companies. Over the past year, Kyle Bauser has issued 12 stock ratings, including strong buy, buy, and hold recommendations. While full access to Kyle Bauser's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kyle Bauser's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

45 Last 5 Years

Buy Recommendations

91.11% 41 Buy Ratings

Companies Covered

20 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	4.4%	2 ratings
Buy	86.7%	39 ratings
Hold	8.9%	4 ratings
Sell	0.0%	0 ratings

Out of 45 total stock ratings issued by Kyle Bauser at Roth Capital, the majority (86.7%) have been Buy recommendations, followed by 8.9% Hold and 4.4% Strong Buy.

Best & Worst Calls

• Best Call

  0000.0%

  INSP

  Sep 2019

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  SIEN

  Nov 2021

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	70.0% of companies on NASDAQ	14 companies
NYSE	20.0% of companies on NYSE	4 companies
NYSEAMERICAN	5.0% of companies on NYSEAMERICAN	1 company
OTCMKTS	5.0% of companies on OTCMKTS	1 company

Kyle Bauser, an analyst at Roth Capital, currently covers 20 companies listed on NASDAQ, NYSE, NYSEAMERICAN and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 17 companies	85.0%
	Computer and Technology 1 company	5.0%
	Business Services 1 company	5.0%
	Industrials 1 company	5.0%

Kyle Bauser of Roth Capital specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Business Services companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 4 companies	20.0%
MED INSTRUMENTS 2 companies	10.0%
SURGICAL & MEDICAL INSTRUMENTS 2 companies	10.0%
MED - BIOMED/GENE 2 companies	10.0%
MED - DRUGS 2 companies	10.0%
ELECTROMEDICAL EQUIPMENT 1 company	5.0%
ELECTRONIC COMPONENTS & ACCESSORIES 1 company	5.0%
MISCELLANEOUS BUSINESS SERVICES 1 company	5.0%
CONTNRS - PPR/PLS 1 company	5.0%
MEDICAL DEVICES 1 company	5.0%
PROCESS CONTROL INSTRUMENTS 1 company	5.0%
PHARMACEUTICAL PREPARATIONS 1 company	5.0%
MEDICAL INFO SYS 1 company	5.0%

About Kyle Bauser

Kyle Bauser, Ph.D. is a Managing Director, Senior Research Analyst at ROTH covering the medical technology sector. He began his career in medtech equity research over 12 years ago at Piper Sandler. He later worked in marketing and corporate development at Vascular Solutions before returning to research at Dougherty & Co where he became Managing Director and Co-Head of Equities. His research primarily focuses on smid cap, underfollowed companies with novel technologies. Kyle studied Mathematical Economics and Pre-Med at Colorado College as an undergraduate and earned a Ph.D. in Economics at the City University of New York Graduate Center.

Follow on LinkedIn

Kyle Bauser's Ratings History at Roth Capital

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
ELMD Electromed	8/27/2025	Boost Price Target	$24.45	$35.00	Buy	$0.00 00.00% ROI
SNWV Sanuwave Health	8/22/2025	Boost Price Target	$44.23	$55.00	Buy	$0.00 00.00% ROI
VREX VAREX IMAGING	8/8/2025	Reiterated Rating	$7.81	$16.00	Buy	$0.00 00.00% ROI
TCMD Tactile Systems Technology	8/5/2025	Reiterated Rating	$11.99	$13.00	Neutral	$0.00 00.00% ROI
SNWV Sanuwave Health	7/29/2025	Initiated Coverage	$35.75	$49.00	Buy	$0.00 00.00% ROI
ELMD Electromed	7/22/2025	Initiated Coverage	$18.13	$29.00	Buy	$0.00 00.00% ROI
INFU InfuSystem	7/22/2025	Initiated Coverage	$5.51	$12.00	Buy	$0.00 00.00% ROI
ELMD Electromed	7/21/2025	Upgrade	$18.69		Strong-Buy	$0.00 00.00% ROI
INFU InfuSystem	7/21/2025	Upgrade	$5.75		Strong-Buy	$0.00 00.00% ROI
TECH Bio-Techne	7/9/2025	Initiated Coverage	$52.68	$65.00	Buy	$0.00 00.00% ROI
ELMD Electromed	2/20/2025	Initiated Coverage	$29.36	$38.00	Buy	$0.00 00.00% ROI
VREX VAREX IMAGING	2/7/2025	Reiterated Rating	$12.06	$22.00	Buy	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.